Journal List > J Korean Ophthalmol Soc > v.54(6) > 1009716

Han, Lee, and Kwak: Two Cases of Intravitreal Ganciclovir Injection for Cytomegalovirus Retinitis

Abstract

Purpose

To report 2 cases of cytomegalovirus retinitis treated with intravitreal ganciclovir.

Case summary

A 29-year-old female (Case 1) who received immunosuppressive therapy with tacrolimus and mycophe-nolate mofetil for 3 months after pancreatic transplantation, was given an intravitreal Bevacizumab injection 4 times in each eye under the suspicion of bilateral central retinal vein occlusion. During follow-up, a new lesion with white opacification and multiple snowballs appeared in the left eye. Suspecting cytomegalovirus retinitis, we administered an intravitreal ganciclovir injection resulting in a decrease of white opacification and improvement of visual acuity. A 66-year-old male (Case 2) who was receiving treatment for general weakness and heart failure, presented with visual disturbance in both eyes. Fundoscopic examination revealed white opacification, multiple snowballs and retinal hemorrhage in the left eye; di-agnostic vitrectomy was performed. Macular edema and subretinal fluid continued after the vitrectomy and the serologic testing revealed an IgG titer positive for cytomegalovirus, therefore, an intravitreal injection of ganciclovir was given. Macular edema and subretinal fluid decreased and visual acuity improved.

Conclusions

Intravitreal ganciclovir can be an effective treatment option for the management of CMV retinitis. J Korean Ophthalmol Soc 2013;54(6):977-981

References

1. Shahnaz S, Choksi MT, Tan IJ. Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease. Mayo Clin Proc. 2003; 78:1412–5.
crossref
2. Diamond C, Thiede H, Perdue T. . Seroepidemiology of human herpesvirus 8 among young men who have sex with men. Sex Transm Dis. 2001; 28:176–83.
crossref
3. Drew WL, Mintz L, Miner RC. . Prevalence of cytomegalovi-rus infection in homosexual men. J Infect Dis. 1981; 143:188–92.
crossref
4. Gallant JE, Moore RD, Richman DD. . Incidence and natural history of cytomegalovirus disease in patients with advanced hu-man immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis. 1992; 166:1223–7.
crossref
5. Evans BG. Management of blinding disease: loss of immunity and superinfection. Eye (Lond). 2005; 19:1035–6.
crossref
6. Stewart MW. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010; 4:285–99.
crossref
7. Langner-Wegscheider BJ, ten Dam-van Loon N, Mura M. . Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis. Can J Ophthalmol. 2010; 45:157–60.
crossref
8. Ausayakhun S, Keenan JD, Ausayakhun S. . Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol. 2012; 153:923–31.
crossref
9. Kabata Y, Takahashi G, Tsuneoka H. Cytomegalovirus retinitis treated with valganciclovir in Wegener's granulomatosis. Clin Ophthalmol. 2012; 6:521–3.
10. Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomega-lovirus infections. Drugs. 1990; 39:597–638.
crossref
11. Huynh N, Daniels AB, Kohanim S, Young LH. Medical treatment for cytomegalovirus retinitis. Int Ophthalmol Clin. 2011; 51:93–103.
crossref
12. Teoh SC, Ou X, Lim TH. Intravitreal ganciclovir maintenance in-jection for cytomegalovirus retinitis: efficacy of a low-volume, in-termediate-dose regimen. Ophthalmology. 2012; 119:588–95.
crossref
13. Pulido J, Peyman GA, Lesar T, Vernot J. Intravitreal toxicity of hy-droxyacyclovir (BW-B759U), a new antiviral agent. Arch Ophthalmol. 1985; 103:840–1.
crossref
14. Henry K, Cantrill H, Fletcher C. . Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus reti-nitis in a patient with AIDS. Am J Ophthalmol. 1987; 103:17–23.
crossref
15. Harris ML, Mathalone MB. Intravitreal ganciclovir in CMV reti-nitis: case report. Br J Ophthalmol. 1989; 73:382–4.
crossref
16. Young SH, Morlet N, Heery S. . High dose intravitreal ganci-clovir in the treatment of cytomegalovirus retinitis. Med J Aust. 1992; 157:370–3.
crossref
17. Cochereau-Massin I, Lehoang P, Lautier-Frau M. . Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus reti-nitis in acquired immune deficiency syndrome. Ophthalmology. 1991; 98:1348–53.
crossref

Figure 1.
Fundus photographs & OCT of both eyes in case 1. (A) Fundus photograph of the left eye shows opaque white lesions at the inferonasal retina. (B) Fundus photograph of the left eye shows disappearance of opaque white lesions. (C) OCT of left eye shows residual macular edema. (D) OCT of left eye shows residual macular edema.
jkos-54-977f1.tif
Figure 2.
Fundus photographs & OCT of both eyes in case 2. (A) Fundus photograph of right eye shows retinal hemorrhage with opaque white lesions in inferior region of the optic disc and atrophic lesions at the temporal region. (B) Fundus photo-graph of the right eye shows improvement of retinal hemorrhage with opaque white lesions. (C) OCT of the right eye shows macular edema and submacular fluid. (D) OCT of the right eye shows no macular edema and submacular fluid.
jkos-54-977f2.tif
TOOLS
Similar articles